Manoj Malhotra

591 total citations
61 papers, 407 citations indexed

About

Manoj Malhotra is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Manoj Malhotra has authored 61 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Psychiatry and Mental health, 33 papers in Pediatrics, Perinatology and Child Health and 21 papers in Cellular and Molecular Neuroscience. Recurrent topics in Manoj Malhotra's work include Epilepsy research and treatment (35 papers), Pharmacological Effects and Toxicity Studies (31 papers) and Neuroscience and Neuropharmacology Research (21 papers). Manoj Malhotra is often cited by papers focused on Epilepsy research and treatment (35 papers), Pharmacological Effects and Toxicity Studies (31 papers) and Neuroscience and Neuropharmacology Research (21 papers). Manoj Malhotra collaborates with scholars based in United States, United Kingdom and Japan. Manoj Malhotra's co-authors include Anna Patten, Betsy Williams, Carlos Perdomo, Robert Wechsler, Bernhard J. Steinhoff, Satinder Aneja, Sharmila B. Mukherjee, Smita N. Deshpande, James W. Wheless and Leock Y. Ngo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Manoj Malhotra

56 papers receiving 395 citations

Peers

Manoj Malhotra
Lorenzo Ferri Italy
Carla Arbasino Italy
Lucia Sukys-Claudino Brazil
Weihong Lin China
Giovanni Regesta Italy
András Holló Hungary
C. A. Galimberti Italy
Roberta Mazza Italy
Dilşad Türkdoğan Türkiye
Tariq Mahmood United Kingdom
Lorenzo Ferri Italy
Manoj Malhotra
Citations per year, relative to Manoj Malhotra Manoj Malhotra (= 1×) peers Lorenzo Ferri

Countries citing papers authored by Manoj Malhotra

Since Specialization
Citations

This map shows the geographic impact of Manoj Malhotra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manoj Malhotra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manoj Malhotra more than expected).

Fields of papers citing papers by Manoj Malhotra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manoj Malhotra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manoj Malhotra. The network helps show where Manoj Malhotra may publish in the future.

Co-authorship network of co-authors of Manoj Malhotra

This figure shows the co-authorship network connecting the top 25 collaborators of Manoj Malhotra. A scholar is included among the top collaborators of Manoj Malhotra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manoj Malhotra. Manoj Malhotra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Drake, Christopher L., Jane Yardley, Kate Pinner, Margaret Moline, & Manoj Malhotra. (2025). Perception of Lemborexant Effectiveness as Assessed by the Patient Global Impression–Insomnia Questionnaire. Nature and Science of Sleep. Volume 17. 557–570. 1 indexed citations
2.
Gotfried, Mark H., Sanford Auerbach, Thien Thanh Dang‐Vu, et al.. (2024). Efficacy and safety of insomnia treatment with lemborexant in older adults: analyses from three clinical trials. Drugs & Aging. 41(9). 741–752. 6 indexed citations
3.
Krystal, Andrew D., Pierre Blier, Larry Culpepper, et al.. (2024). Efficacy and safety of lemborexant in subjects with insomnia disorder receiving medications for depression or anxiety symptoms. Neuropsychopharmacology Reports. 45(1). e12509–e12509. 2 indexed citations
4.
5.
Chinvarun, Yotin, Rafael Toledano, Tim Wehner, et al.. (2023). Perampanel Monotherapy for Focal and Generalized Epilepsy in Clinical Practice. Acta Neurologica Scandinavica. 2023. 1–12. 1 indexed citations
6.
7.
Piña-Garza, J. Eric, Vicente Villanueva, William E. Rosenfeld, et al.. (2022). Assessment of the long-term efficacy and safety of adjunctive perampanel in adolescent patients with epilepsy: Post hoc analysis of open-label extension studies. Epilepsy & Behavior. 135. 108901–108901. 5 indexed citations
8.
Wechsler, Robert, James W. Wheless, Muhammad Zafar, et al.. (2021). PROVE: Retrospective, non‐interventional, Phase IV study of perampanel in real‐world clinical care of patients with epilepsy. Epilepsia Open. 7(2). 293–305. 18 indexed citations
9.
Kanner, Andrés M., Anna Patten, Alan B. Ettinger, et al.. (2021). Does a psychiatric history play a role in the development of psychiatric adverse events to perampanel… and to placebo?. Epilepsy & Behavior. 125. 108380–108380. 15 indexed citations
10.
Maguire, Melissa, Elinor Ben‐Menachem, Anna Patten, Manoj Malhotra, & Leock Y. Ngo. (2021). A post-approval observational study to evaluate the safety and tolerability of perampanel as an add-on therapy in adolescent, adult, and elderly patients with epilepsy. Epilepsy & Behavior. 126. 108483–108483. 11 indexed citations
11.
Arzimanoglou, Alexis, Milka Pringsheim, Gerhard Kluger, et al.. (2021). Safety and efficacy of rufinamide in children and adults with Lennox-Gastaut syndrome: A post hoc analysis from Study 022. Epilepsy & Behavior. 124. 108275–108275. 5 indexed citations
12.
Alsaadi, Taoufik, Manuel Toledo, Eugen Trinka, et al.. (2021). Perampanel Monotherapy in Epilepsy Patients with Focal and Generalized Seizures: Real-World Experience (1641). Neurology. 96(15_supplement).
13.
Wheless, James W., Robert Wechsler, Marcelo E. Lancman, et al.. (2020). Perampanel in real‐world clinical care of patients with epilepsy: Interim analysis of a phase IV study. Epilepsia Open. 6(1). 79–89. 10 indexed citations
14.
Rektor, Ivan, Gregory L. Krauss, Yushi Inoue, et al.. (2020). Assessment of the long‐term efficacy and safety of adjunctive perampanel in tonic‐clonic seizures: Analysis of four open‐label extension studies. Epilepsia. 61(7). 1491–1502. 15 indexed citations
15.
Piña-Garza, J. Eric, William E. Rosenfeld, Vicente Villanueva, et al.. (2020). Efficacy and safety of adjunctive perampanel in adolescent patients with epilepsy: Post hoc analysis of six randomized studies. Epilepsy & Behavior. 104(Pt A). 106876–106876. 28 indexed citations
16.
Brandt, Christian, Robert Wechsler, Terence J. O’Brien, et al.. (2020). Adjunctive perampanel and myoclonic and absence seizures: Post hoc analysis of data from study 332 in patients with idiopathic generalized epilepsy. Seizure. 80. 115–123. 19 indexed citations
17.
18.
Sheikh, Shehryar, et al.. (2019). Elevated Healthcare Burden Among Patients with Active Generalized Tonic-Clonic (GTC) Convulsions (P3.5-027). Neurology. 92(15_supplement). 1 indexed citations
19.
Cramer, Joyce A., et al.. (2019). Risk of hospitalization among patients with epilepsy using long versus short half-life adjunctive antiepileptic drugs. Epilepsy & Behavior. 102. 106634–106634. 4 indexed citations
20.
Fahrbach, Kyle, Amber Martin, Edward Kim, et al.. (2013). Relating relapse and T2 lesion changes to disability progression in multiple sclerosis: a systematic literature review and regression analysis. BMC Neurology. 13(1). 180–180. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lorenzo Ferri Breakdown of academic impact, for papers by Carla Arbasino Breakdown of academic impact, for papers by Lucia Sukys-Claudino Breakdown of academic impact, for papers by Weihong Lin Breakdown of academic impact, for papers by Giovanni Regesta Breakdown of academic impact, for papers by András Holló Breakdown of academic impact, for papers by C. A. Galimberti Breakdown of academic impact, for papers by Roberta Mazza Breakdown of academic impact, for papers by Dilşad Türkdoğan Breakdown of academic impact, for papers by Tariq Mahmood
Rankless by CCL
2026